Low KLF17 expression is observed in most human cancers, including colorectal carcinoma, esophageal carcinoma, hepatocellular carcinoma, lung adenocarcinoma, and gastric cancer [12,14,15,16,23,24]. Here, KLF17 is linked to lung adenocarcinoma.